compensate for one another, although there is no evidence of true biochemical redundancy. The genomes of lower organisms, such as Caenorhabditis elegans, Drosophila melanogaster and Danio rerio, harbor single ERM orthologues; in fact, ERMs appeared evolutionarily during the transition to multicellularity and an ERM-like protein is encoded by the genome of the choanoflagellate Monosiga brevicolis, which is thought to be the closest metazoan ancestor. Interestingly, within the FERM protein superfamily tree the ERMs form a tightly related branch that includes one other family member and its orthologues: the neurofibromatosis type 2 tumor suppressor protein, merlin (moesin, ezrin, radixin like protein).
The structure of the ERM proteins is integral to what they do. They have an amino-terminal clover-leaf-shaped FERM domain that harbors many protein interacting sites. This domain is connected to a carboxy-terminal actinbinding domain via a central a-helix-rich segment. The carboxy-terminal and a-helical domains can both fold back upon the FERM domain and mask both actin-binding and FERMdomain interactions. Regulation of this conformation by phosphorylation and phospholipid binding modulates ERM activity. In this way, the ERMs can assemble protein complexes at the membrane and link them to the actin cytoskeleton in a regulated fashion. The ERMs therefore seem designed to do several things, perhaps all at once: alter the mechanical properties of the
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What are the ERM proteins? Three closely related proteins -ezrin, radixin and moesin -that link membraneassociated proteins directly to actin filaments at the cell cortex. Cells and tissues use this crosslinking activity to create architecturally and functionally distinct cortical domains, such as the apical brush border of the small intestine or stereocilia of the inner ear. The ERM proteins are not, however, static connectors, even within these seemingly inert structures. In fact, the ERM proteins are also critical modulators of cortical architecture during highly dynamic cell behaviors, such as mitosis, migration and junction remodeling. The more we learn about these versatile little machines, the more we appreciate the fact that the morphology of a cell is in a constant state of motion.
How did they get their names?
Ezrin, the first ERM protein identified, was originally isolated from chicken intestinal epithelial brush borders in 1983 and named after Ezra Cornell, a founder of Cornell University. Radixin was isolated from rat hepatocyte cell junctions and found to localize to the cytoplasmic surface of adherens junctions in many cell types; hence it was named for the Latin word radix, which means root or foundation. Finally, moesin was originally isolated from the bovine uterus as a potential heparan sulfate-binding protein and dubbed membrane-organizing extension spike protein. The appreciation that these are closely related proteins that localize to the interface between the plasma membrane and the cortical actin cytoskeleton soon followed, along with comparative studies of their expression, localization and function.
What do the ERM proteins look like?
The ERMs are prototypic members of the band 4.1 or FERM (four-pointone-ezrin-radixin-moesin) protein superfamily. The mammalian ERM proteins are 70-75 kDa in molecular weight and are very similar to one another, having ~72-80% amino acid identity; indeed, it is generally assumed that they can functionally Quick guide cell cortex; control the local distribution and abundance of specific membrane receptors; and locally assemble regulatory protein complexes that impact one or both of those activities (Figure 1) .
How do the ERM proteins affect cell architecture? One fundamental action of the ERMs is to crosslink actin filaments to the membrane. The density and organization of such crosslinks can dramatically alter the physical properties of the cell cortex. For example, ERM activation broadly stiffens the cortex as cells round up during mitosis, providing mechanical support for the mitotic spindle, which applies force to the cortex during cell division. Cells also utilize local ERM activation and increased membrane cytoskeleton crosslinking to create subcellular appendages and domains. Examples include specialized actin-based structures, such as microvilli, stereocilia and kidney podocyte foot processes. A close look reveals that each of these structures is in constant motion, replenishing both core actin filaments and associated membrane receptors and complexes, suggesting a dynamic role for ERMs in their maintenance. Local ERM activation is also important for the retraction of transient membrane blebs that form when the actomyosin cytoskeleton contracts beneath the plasma membrane as cells change their shape. In another example, local moesin activation and cortical stiffening immobilizes E-cadherin-containing microdomains -known as spot Figure 1 . Model of how the ERM proteins could simultaneously establish crosslinks between the membrane and cortical actin, position membrane receptors and control their activity by bringing a specific regulator into close proximity with the receptor. This is just one example of the many kinds of complexes these versatile proteins could assemble and regulate. adherens junctions -within the apical junctional region of the Drosophila embryonic epithelium; this may provide mechanical stability during the junctional remodeling that accompanies tissue morphogenesis. Too much or too little ERM-mediated crosslinking impairs the migration of mesendoderm cells during zebrafish gastrulation and homing lymphocytes in mice. This is due in part to the cells' inability to form protrusive processes that steer their migration. A better understanding of how ERM activation contributes to migration in these normal contexts will likely help to explain the association between excess ERM activation and tumor metastasis.
How do the ERM proteins affect membrane receptors?
The ERM FERM domain can associate with membrane receptors either directly, via positively charged residues in the juxtamembrane region of the receptors themselves, or indirectly, via PDZdomain-containing adaptors such as NHE-RF1 (also called EBP50). In fact, structural studies suggest that NHE-RF1 and transmembrane receptors may not be able to associate with the FERM domain at the same time. The ERMs therefore seem designed to assemble multiple different protein complexes that each contain individual receptors. Interaction with the ERMs can affect membrane receptors in two major ways: by tethering them to the cortical cytoskeleton and thereby controlling their distribution on the plasma membrane; and/or by bringing critical regulators into close proximity with the receptors. In an example that features both activities, ezrin assembles a complex that includes the cystic fibrosis transmembrane conductance regulator (CFTR), NHE-RF1 adaptor, actin and protein kinase A (PKA; which associates with ezrin and activates CFTR). This complex controls the plasma membrane availability, activation and cytoskeletal association of CFTR. In fact the common mutant version of CFTR (DF508) that causes cystic fibrosis exhibits defective surface abundance and activity, but increased levels of the CFTR-NHE-RF1-ezrin-PKA-actin complex can rescue that defect in cultured airway epithelial cells.
Another important example of ERMmediated control of membrane receptor distribution involves the ezrin-NHE-RF1-actin-dependent exclusion of the transmembrane glycoprotein podocalyxin from entering the membrane of the primary ciliuma microtubule-based appendage that functions as a sensory organelle and represents a distinct membrane compartment. This demonstrates how ezrin-NHE-RF1-dependent tethering can 'sort' receptors into different membrane compartments, a principle that may extend to many other receptors and may also apply to the sorting of receptors on intracellular membranes during receptor trafficking.
Are the functions of ERM proteins in controlling cell architecture and receptor distribution distinct or coordinated? Most models of ERM activation depict a dramatic 'opening' of the conformation of the protein that simultaneously exposes binding sites for actin, membrane proteins and regulators. Therefore, it seems likely that these activities are actively coordinated by the ERMs. With this in mind, it will be important to better define the breadth and complexity of ERM-interacting complexes. For example, what are the ERM-binding partners during mitotic cell rounding, bleb retraction and migration? How does actin crosslinking affect the activity of other ERM-associated receptors? How many different ERMcontaining complexes are there in a given cell? These questions will keep cell biologists busy for a long time.
Where can I find out more?
